SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Referral — Billie Holiday — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBillie Holiday
Date of birth1915-04-07
IdentifiersMRN HR-ML010-SYN-TD; SSN (made up) 000-10-4472
Document date1948-04-20
AuthorConstance Mayfield, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Severe opioid use disorder and moderate alcohol use disorder in a 33-year-old singer, five weeks after release from about ten months in custody, when her tolerance is low and her overdose risk high. Buprenorphine with naloxone was started today. Please confirm the medication plan and dose, advise on a medicine for her drinking that is safe with buprenorphine, and help set the monitoring and recovery plan. [S]

Urgency: Within one week, on the same day as her one-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Heroin use since her twenties, becoming severe in the last few years; she has sought treatment before. No opioid use since release and no withdrawal today; no medication for opioid use disorder was offered in custody. Drinking four or five drinks on most performance nights since release (AUDIT-C 8; PEth 312 ng/mL); no history of withdrawal seizures or delirium. DAST-10 7. PHQ-9 9, item 9 scored 0; structured safety assessment shows no suicidal thoughts. Urine pregnancy test negative. Today: buprenorphine with naloxone, 4 mg today and then 8 mg daily; naloxone nasal spray; thiamine; Tdap, PCV20, and first doses of hepatitis A and B vaccines. Blood tests drawn today: AST 52, ALT 38, GGT 84 U/L, albumin 4.0 g/dL, bilirubin 0.7 mg/dL, MCV 101 fL, platelets 236, creatinine 0.72 mg/dL; hepatitis C antibody, hepatitis B triple panel, and HIV test sent. She has been singled out by law enforcement many times and is wary of clinics; she asks that she decide what is shared and with whom [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue dailyOne film under the tongue daily after a 4 mg first doseSublingual route1948-04-20 to 1948-04-27completedS
Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no responseNasal route1948-04-20activeS
Thiamine 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1948-04-20 to 1948-10-19completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin useactiveconfirmed F11.20S — Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use.
Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's deathactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
about 1943Heroin use from the early 1940s, becoming a severe addiction in the late 1940s; sought treatment for it at least onceD (CLM-0003, CLM-0005)
October 1945Heavier drinking and increased drug use after her mother's deathD (CLM-0002)
March 16, 1948Federal custody after a narcotics possession conviction, about ten months with enforced abstinence; released earlyD (CLM-0004)

Family History

RelativeConditionAge at deathEvidence
motherDied in 1945; cause not recorded in the cited sourceD (CLM-0002)

Social History

Vital Signs

DateMeasureValueUnitProvenance
1948-04-20Body height165cmS
1948-04-20Body weight68kgS
1948-04-20Body mass index (BMI) [Ratio]25kg/m2S
1948-04-20Systolic blood pressure126mm[Hg]S
1948-04-20Diastolic blood pressure80mm[Hg]S
1948-04-20Heart rate84/minS
1948-04-20Respiratory rate16/minS
1948-04-20Body temperature36.8CelS
1948-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1948-04-20Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
1948-04-20MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
1948-04-20Platelets [#/volume] in Blood by Automated count23610*3/uL150-400 10*3/uLNormalS
1948-04-20Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1948-04-20Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
1948-04-20Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
1948-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M113mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1948-04-20Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
1948-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma52U/L10-40 U/LHighS
1948-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
1948-04-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma84U/L5-40 U/LHighS
1948-04-20Albumin [Mass/volume] in Serum or Plasma4g/dL3.5-5 g/dLNormalS
1948-04-20Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
1948-04-20Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay0.09{s_co_ratio}Below 1.00 is nonreactiveNormalS
1948-04-20Hepatitis B virus surface Ab [Units/volume] in Serum3m[IU]/mL>=10 m[IU]/mLLowS
1948-04-20Phosphatidylethanol [Mass/volume] in Blood312ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
1948-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
1948-04-20Total score [AUDIT-C]8{score}S
1948-04-20Total score [DAST-10]7{score}S

Assessment

Plan of Treatment